These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2892540)

  • 1. Reversal of helpless behavior in rats by putative 5-HT1A agonists.
    Giral P; Martin P; Soubrié P; Simon P
    Biol Psychiatry; 1988 Feb; 23(3):237-42. PubMed ID: 2892540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism.
    Martin P; Beninger RJ; Hamon M; Puech AJ
    Behav Brain Res; 1990 May; 38(2):135-44. PubMed ID: 2141988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.
    Martin P
    Psychopharmacology (Berl); 1991; 104(2):275-8. PubMed ID: 1678895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
    Gilbert F; Dourish CT
    Psychopharmacology (Berl); 1987; 93(3):349-52. PubMed ID: 2893412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
    Hiner BC; Mauk MD; Peroutka SJ; Kocsis JD
    Brain Res; 1988 Sep; 461(1):1-9. PubMed ID: 2906267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
    Gilbert F; Dourish CT; Brazell C; McClue S; Stahl SM
    Psychoneuroendocrinology; 1988; 13(6):471-8. PubMed ID: 2907164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigm.
    Martin P; Tissier MH; Adrien J; Puech AJ
    Life Sci; 1991; 48(26):2505-11. PubMed ID: 1828519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B; Hjorth S; Engel JA
    Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of buspirone differ from those of gepirone and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on unpunished responding of pigeons.
    Barrett JE; Fleck-Kandath C; Mansbach RS
    Pharmacol Biochem Behav; 1988 Jul; 30(3):723-7. PubMed ID: 2905470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
    Yocca FD; Wright RN; Margraf RR; Eison AS
    Pharmacol Biochem Behav; 1990 Jan; 35(1):251-4. PubMed ID: 2138331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by 8-hydroxy-2-(di-n-propylamino) tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors.
    Hirose A; Tsuji R; Shimizu H; Tatsuno T; Tanaka H; Kumasaka Y; Nakamura M
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):8-13. PubMed ID: 1969119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5-HT1A selective anxiolytics on lordosis behavior: interactions with progesterone.
    Mendelson SD; Gorzalka BB
    Eur J Pharmacol; 1986 Dec; 132(2-3):323-6. PubMed ID: 2880737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands.
    Mansbach RS; Geyer MA
    Eur J Pharmacol; 1988 Nov; 156(3):375-83. PubMed ID: 2975225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of cerebellar Purkinje cells to serotonin and the 5-HT1A agonists 8-OH-DPAT and ipsapirone in vitro.
    Darrow EJ; Strahlendorf HK; Strahlendorf JC
    Eur J Pharmacol; 1990 Jan; 175(2):145-53. PubMed ID: 1968842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression.
    Kennett GA; Dourish CT; Curzon G
    Eur J Pharmacol; 1987 Feb; 134(3):265-74. PubMed ID: 2883013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of neuronal activity in the hippocampus by 5-hydroxytryptamine and 5-hydroxytryptamine1A selective drugs.
    Peroutka SJ; Mauk MD; Kocsis JD
    Neuropharmacology; 1987; 26(2-3):139-46. PubMed ID: 2884586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
    Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
    Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.